Kezar Life Sciences Inc (KZR) earnings · last reported Nov 12, 2025
Next report
KZR has not announced its next report date and there is not enough history to project one.
Earnings move
- Options price in
- — No upcoming report date.
- Average move after earnings
- ±2.3% Absolute close-to-close move, 3 reports
Options-implied move: the at-the-money straddle (call + put) on the first expiry after the report, divided by the stock’s close, from EODHD end-of-day option chains. It is what the options market prices as the absolute move to that expiry, not a forecast of direction. Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Per-report moves, gaps, moves vs SPY and the sector, beat/miss asymmetry and implied vs actual are in Lician Pro below.
Latest result
EPSGAAP
−$1.53
vs −$0.26 est. −488.5%
GAAP diluted EPS, SEC 10-Q
Revenue
—
No revenue consensus stored
EPS actuals are checked against the SEC filing and the company’s earnings press release (8-K EX-99.1). A company that reports only GAAP EPS is graded on its SEC diluted EPS; one that reports adjusted EPS is graded on the provider’s adjusted figure when the release confirms it. A figure that matches neither is shown as unverified, with no beat or miss. Revenue actuals come from the SEC filing of the same quarter where we have it.
Beat / miss history
- Missed EPS 2 quarters in a row
- Beat EPS in 1 of 3
- Nov 12, 2025MissEPS −$1.53GAAP vs −$0.26 −488.5%Rev — vs —
- Aug 13, 2025MissEPS −$1.87GAAP vs −$0.28 −567.9%Rev — vs —
- Nov 13, 2024BeatEPS −$2.78GAAP vs −$3.15 +11.7%Rev $0 vs $800.00K −100.0%
| Reported | Quarter | EPS est. | EPS actual | Surprise | Revenue est. | Revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Sep 2025 | −$0.26 | −$1.53GAAP | −488.5% | — | — | — |
| Aug 13, 2025 | Jun 2025 | −$0.28 | −$1.87GAAP | −567.9% | — | — | — |
| Nov 13, 2024 | Sep 2024 | −$3.15 | −$2.78GAAP | +11.7% | $800.00K | $0SEC | −100.0% |
Only 3 reported quarters are stored for KZR so far. Older quarters are added as we load each company’s earnings history; nothing is filled in by estimate.
Earnings documents
No earnings 8-K (item 2.02) is stored for this report yet. All KZR filings: SEC filings.
Documents link to SEC EDGAR. Lician does not publish earnings-call transcripts.
KZR stock after earnings
- Average move after earnings: ±2.3% over the last 3 measured reports.
Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Earnings move details.
| Quarter | Revenue | EPS | YoY |
|---|---|---|---|
| Q1 FY26 | — | −$0.78 | — |
| Q3 FY25 | — | −$1.53 | — |
| Q2 FY25 | — | −$1.87 | — |
| Q1 FY25 | — | −$2.27 | — |
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported KZR revenue for 2025-12-31 was $0. Net income was -$56.0M. KZR currently screens at market cap $53.9M.
When the next KZR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for KZR. We will not invent a beat or miss.
Not investment advice. Full KZR research stays on the stock page; the tape stays on the quote page.
KZR earnings FAQ
Did KZR beat earnings estimates last quarter?
No. On Nov 12, 2025 Kezar Life Sciences Inc (KZR) reported adjusted EPS of −$1.53 against a −$0.26 consensus (−488.5%), a miss.
How does KZR stock move after earnings?
Over its last 3 measured reports, KZR moved an average of ±2.3% (absolute close-to-close move) after earnings.
How often does KZR beat EPS estimates?
Kezar Life Sciences Inc (KZR) beat the EPS consensus in 1 of its last 3 reported quarters.
What is KZR's latest net income?
Latest cached Kezar Life Sciences Inc (KZR) net income was -$56.0M. Statements: https://lician.com/financials/kzr
What is KZR's latest diluted EPS?
Latest cached Kezar Life Sciences Inc (KZR) diluted EPS for Dec 31, 2025 was -$7.66.
What period does the latest KZR earnings print cover?
The latest cached Kezar Life Sciences Inc (KZR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are KZR earnings listed?
Cached earnings facts for Kezar Life Sciences Inc (KZR) are listed at https://lician.com/earnings/kzr. Statements: https://lician.com/financials/kzr
Not investment advice.